Treatment of drug-resistant bacteria is a significant unmet medical need. This challenge can be met only by the discovery and development of new antibiotics. Antisense technology is one of the newest discovery tools that provides enhanced sensitivity for detection of antibacterials, and has led to the discovery of a number of interesting new antibacterial natural products. Continued utilization of this technology led to the discovery of three new bicyclic lactones, glabramycins A-C, from a Neosartorya glabra strain. Glabramycin C showed strong antibiotic activity against Streptococcus pneumoniae (MIC 2 lg ml À1 ) and modest antibiotic activity against Staphylococcus aureus (MIC 16 lg ml À1 ). The isolation, structure, relative configuration and antibacterial activity, and plausible biogenesis of these compounds have been discussed.
INTRODUCTION
The discovery and development of clinically useful antibiotic classes, such as, the aminoglycosides, macrolides and tetracyclines, have clearly shown that bacterial protein synthesis is a viable target for antibacterial drug discovery. 1, 2 The bacterial ribosome responsible for protein synthesis consists of a small 30S and a large 50S subunit. The ribosomal subunit (aka S4), referred to as RpsD, is a component of the 30S subunit. [3] [4] [5] The RpsD protein is encoded by the rpsD gene, which is essential and resides in an operon containing only one other gene, SAV1718, which is a nonessential gene. 6, 7 Therefore, this gene was selected as a drug-target for the discovery of antibacterial agents.
For antibiotic discovery targeting the rpsD gene, we constructed a Staphylococcus aureus S1-782B strain expressing antisense RNA under xylose control, leading to hypersensitivity against RpsD inhibitors. To implement this approach for drug discovery, we designed a two-plate assay in which one plate was seeded with an rpsD antisense S. aureus strain and the other with an S. aureus EP 167 (control) strain. A similar general methodology led to the discovery of platensimycin and platencin. [8] [9] [10] [11] [12] [13] The screening of over 138 000 microbial extracts against rpsD two-plate antisense whole-cell assay led to the isolation of a series of interesting new compounds exemplified by lucensimycins, [14] [15] [16] coniothyrione, 17 pleosporone, 18 phaeosphenone, 19 and okilactomycin. 20 Continued screening and follow-up of one of the active extracts produced by Neosartorya glabra led to the isolation of three macrolactones namely, glabramycin A-C (1-3, Figure 1 ). The isolation, structure elucidation, relative configuration and antibacterial activity of the glabramycins (1-3) are described.
RESULTS AND DISCUSSION
The producing organism was isolated from a soil sample collected from Candamia, Spain. The strain was identified as Neosartorya glabra by sequencing the large subunit of DNA of the D1D2 region and by tracing the phylogenetic relationships. The strain was grown in a submerged fermentation for 14 days and compounds were extracted with an equal volume of acetone. The extract was chromatographed on Amberchrome, a capture resin, followed by reversed-phase C 8 HPLC to give 1 (7 mg, 7 mg l À1 ), 2 (1.9 mg, 1.9 mg l À1 ) and 3 (1 mg, 1 mg l À1 ), each as yellow gums.
Glabramycin A (1), the most abundant of the three compounds, showed a molecular formula C 22 H 24 O 6 as deduced from the HRESIFTMS data. The 13 C NMR spectrum and distortionless enhancement by polarization transfer (DEPT) analysis of 1 showed signals for one methyl, four methylenes, ten methines and seven quaternary carbons (Table 1) . The 1 H NMR spectrum showed signals for four olefinic methine doublet of doublets with J¼15 and 11 Hz, and two methine doublets with J¼15 Hz. The COSY correlations of these six olefinic methines indicated the presence of an E-triene in which each end terminated with a quaternary carbon. The methine (d H 5.90) at one end of the triene chain showed heteronuclear multiple bond correlations (HMBCs) to a carboxyl carbon at d C 170.3, and a carboxylic group was thus placed at one end of the triene. The terminal methine (d H 6.00) at the other end of the triene chain showed HMBC correlations to two quaternary olefinic carbons resonating at d C 167.4 and d C 108.6, allowing for further extension of the triene chain. (C-14) established its connection to the phenyl group. The HMBC correlation of the methine proton (d H 5.30)to an ester carbonyl at d C 164.7 (C-22) allowed for the linkage of this carbonyl and the methine in the form of a lactone ring. Finally, the ester carbonyl C-22 was connected to the olefinic carbon C-9 (d C 108.6) to form the macrocyclic lactone, to satisfy the degrees of unsaturation and the molecular formula. This assignment was supported by the 13 C chemical shifts of C-8, C-9 and C-22. The substitution around the phenyl ring was confirmed by HMBC correlations of the aromatic protons and supported by HMBC correlations of the benzylic methylene protons ( Figure 2 ).
The structures for glabramycins, B (2) and C (3), were determined by comparison of 13 C and 1 H NMR spectral data with 1 (Table 1 ). Table 1 1 H (600 MHz) and 13 C (125 MHz)-NMR assignments of glabramycin A (1), B (2) and C (3) 3) allowed the placement of a carbonyl group at C-14 in the cyclohexanone ring. The ether bridge between C8 and C11 made the dihydrofuran ring that satisfied the molecular formula. The relative configurations at C-10, C-11 and C-15 were established from the magnitude of the scalar couplings. H-10 resonated as a triplet with J¼9.6 Hz because of axial-axial couplings both from H-11 and H-15, thus establishing an anti relationship between these three protons and a trans-ring fusion. Glabramycin C (3) showed a molecular formula that was isomeric to that of 1. Comparison of the 1 H and 13 C NMR spectra of 3 with those of compound 2 indicated the presence of a pair of olefinic protons, d H 6.23 (d, J¼10.5 Hz) and 6.87 (dd, J¼10.5, 4.5 Hz), which were assigned to H-13 and H-12 by COSY correlations and confirmed by their HMBC correlations to an upfield shifted C-14 carbonyl (d C 198.7), thus assigning structure 3 for glabramycin C (Table 1) .
On the basis of these data, structures 1, 2 and 3, with relative configurations, were assigned for glabramycins A, B and C, respectively. Biogenetically, these compounds are likely to originate from a polyketide pathway by condensation of 11 acetate units to a undecaketide, which likely undergoes cyclization, reduction and dehydration to produce compound 1, which then produces compounds 3 and 2.
Biological activities All three glabramycins were tested in the S. aureus antisense rpsDsensitized two-plate differential sensitivity assay. Glabramycin C showed the most potent activity in this assay and showed a minimum detection concentration (MDC) of 62 mg ml À1 . At this concentration, a more than 5 mm zone differential was observed with a 10.78 mm zone of inhibition on the antisense plate vs a 5.63 mm zone of inhibition on the control plate. The size of the zone of clearance was dose dependent, and at 500 mg ml À1 , it produced a zone of clearance of 16.89 and 6.8 mm on the antisense and the control plate, respectively. The other two compounds were less active. Glabramycin A was approximately four-fold less active and showed intermediate activity with MDC of 250 mg ml À1 , producing zone sizes of 11.24 and 6.25 mm on the antisense and the control plate, respectively. The MDC of glabramycin B was greater than 500 mg ml À1 . Glabramycin C showed better activity against a panel of bacteria used in this assay. It inhibited S. aureus growth with MIC values of 16 mg ml À1 (Table 2 ). Glabramycin C exhibited a similar activity against Bacillus subtilis, but was less active against Enterococcus faecalis (MIC 432 mg ml À1 ). The best activity was against Streptococcus pneumoniae regardless of the medium used, and inhibited the growth with an MIC value of 2 mg ml À1 . Glabramycins A and B were significantly less active, see Table 2 . None of these compounds inhibited growth of Gram-negative bacteria or fungi Candida albicans. Mechanistically, glabramycin A, the most abundant of the three, showed 2-3-fold preferential inhibition of RNA synthesis (IC 50 10 mg ml À1 ) compared with DNA and protein synthesis in a macromolecular synthesis assay (Figure 3) . Inhibition of RNA synthesis, IC 50 (10 mg ml À1 ), of S. aureus is 10 times more potent than the MIC value (100 mg ml À1 ) against the same S. aureus strain. Why the compounds discovered in this assay preferentially inhibit RNA synthesis rather than the expected protein synthesis is not clear and requires further investigation.
No compounds have earlier been reported from N. glabra strain, but a large number of biologically active compounds have been reported from genera Neosartorya, for example, the angiogenesis inhibitor, azaspirene. 21 It seems that the most chemically studied species is Neosartorya fischeri, which is known to produce substance P inhibitors namely the fiscalins, 22 the toxin fischerin 23 and the tremorgenic mycotoxins, fumitremorgins, 23 neosartorrin, 24 and terreins. 25 In conclusion, it is evident that the antisense screening approach provides higher sensitivity and allows the discovery of antibiotics with weaker activity, exemplified by the discovery of the three new compounds, glabramycins A-C. One of the three compounds showed moderate antibacterial activity without being a general toxin and can be exploited further. Screening using an antisense sensitized rpsD strains of S. aureus led to the isolation of a number of antibacterial agents that do not preferentially inhibit protein synthesis but often RNA synthesis. Understanding of this phenomenon requires further study. 14, 15, [17] [18] [19] Although lack of selectivity for protein synthesis inhibition by compounds discovered by rpsD-sensitized antisense screening is perplexing, it cannot be merely explained as a generalized technology artifact, because a similar screening approach using a fabFsensitized strain led to the discoveries of platensimycin and platencin, highly selective fatty-acid synthesis inhibitors. 10, 11 
EXPERIMENTAL SECTION
For general experimental procedure, see, for example, Zhang et al. 26 
Producing organism
The N. glabra (MF7030, F-155,700) strains were isolated from hot waterpasteurized soil collected from Candamia, near Valdefresno province of Leó n, Spain. The ascomata, ascospores and conidial states were observed on malt yeast extract agar and were readily recognized as a species of Neosartorya (Ascomycota, Eurotiales).
The DNA of strain F-155,700 was extracted and used as a template for polymerase chain reaction (PCR) reactions. The D1D2 region of the large subunit of ribosomal DNA (LSU rDNA) was amplified and sequenced to aid in identification and to infer phylogenetic relationships of the strains to other fungi. The sequences were used to query GenBank for similar ribosomal sequences. The best matches with the large subunit (LSU) region and the percentage similarities were: N. glabra (U28456) 99%.
Inoculum was prepared by inoculating agar plugs into a 250 ml Erlenmeyer flask containing 60 ml seed medium of the following composition: g l À1 in distilled water (corn steep powder, 2. before the inoculation of the production medium. The production medium, designated asWS80, consisted of g/l in distilled water (whole wheat flour (Pillsbury), 50; xylose, 40; and fructose, 40). The 100 ml medium aliquots was dispensed in 500 ml Erlenmeyer flasks, inoculated with 1% volume of the seed culture, and were agitated for 14 days at 22 1C.
Extraction and isolation of glabramycins
One l fermentation broth (10 flasks) was extracted with one l acetone by shaking for 1 h after the harvest. The acetone extract (2 l) was evaporated under reduced pressure to less than one liter and further diluted with 500 ml water and loaded onto a 50 cc Amberchrome CG161 m (Rohm & Haas, Reading, PA, USA) column. The column was eluted with a 100 min 10-100% aqueous methanol-gradient. The activity was detected in a late eluting band. The active fraction (600 mg) was further purified by repeated reversed-phase HPLC (50% aqueous CH 3 CN + 0.1% TFA on a Zorbax SB C 8, 24Â250 mm, Agilent Technologies, Santa Clara, CA, USA). The identical fractions were pooled from 10 runs and lyophilized to afford glabramycin A (7 mg, 7 mg/l), glabramycin B (1.9 mg, 1.9 mg/l) and glabramycin C (1 mg, 1 mg/l) as yellow gums.
Glabramycin 
Two-plate differential sensitivity rpsD assay
Staphyloccus aureus cells (RN450) carrying plasmid S1-782B bearing antisense to rpsD (AS-RNA strain) or a vector (control strain) were inoculated from a frozen vial source into a tube containing 3 ml of Miller's LB Broth (Invitrogen, Carlsbad, CA, USA) plus 34 mg ml À1 of chloramphenicol. Tubes were incubated at 37 1C at 220 r.p.m. for 18-20 h and kept at room temperature (23 1C) until use. Miller's LB broth was supplemented with 1.2% Select agar (Invitrogen), 0.2% glucose, 15 mg ml À1 chloramphenicol and 12 mM of xylose (only for the antisense strain). The OD 600 of the culture was measured and diluted to 1/1000, and an OD 3.0 culture was inoculated. Next, 100 ml of the culture media was poured into each NUNC plate, the well-caster templates were placed into the agar and the agar was allowed to solidify. Thereafter, 20 ml of the test samples were added to the wells and the plates were incubated at 37 1C for 18 h and zones of inhibition were measured. MDC (minimum detection concentration) values were determined by two-fold serial dilution.
Antibiotic assay (MIC)
The MIC (minimum inhibitory concentration) against each of the strains was determined as described earlier and under the guidelines of the National Laboratory Standards Institute (NLSI). The Cells were inoculated at 10 5 cfu ml À1 , followed by incubation at 37 1C with a 2-fold serial dilution of compounds in the growth medium for 20 h. MIC is defined as the lowest concentration of an antibiotic inhibiting visible growth.
Macromolecular synthesis inhibition
The assay was carried out as described earlier. Briefly, mid-log (A 600 ¼0.5-0.6) S. aureus growths were incubated with an increasing concentration of each inhibitor at 37 1C for 20 min with 1 mCi ml À1 6-[ 3 H]thymidine, 1 mCi ml À1 5,6-[ 3 H]uracil or 5 mCi ml À1 4,5-[ 3 H]leucine, to measure DNA, RNA and protein synthesis, respectively. The reaction was stopped by the addition of 10% trichloroacetic acid and the cells were harvested using a glass fiber filter Discovery and antibacterial activity of glabramycin A-C H Jayasuriya et al
